metformin and dabigatran

metformin has been researched along with dabigatran in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA	1
Avvisati, G; Bressi, E; Cerchiara, E; De Caterina, R; Di Sciascio, G; Giannetti, B; Patti, G; Veneri, AD	1
Byon, W; Chang, C; Diehl, A; Dowty, M; Graham, D; Le, V; Luo, L; Malhotra, B; Mathialagan, S; Raha, N; Rodrigues, AD; Tripathy, S; Vourvahis, M	1

Trials

1 trial(s) available for metformin and dabigatran

Article	Year
Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous Biomarkers. Clinical pharmacology and therapeutics, 2022, Volume: 112, Issue:3 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biomarkers; Cross-Over Studies; Dabigatran; Drug Interactions; Humans; Metformin; Neoplasm Proteins; Organic Cation Transport Proteins; Pharmaceutical Preparations; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2022

Article

Year

Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous Biomarkers.

Clinical pharmacology and therapeutics, 2022, Volume: 112, Issue:3

Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biomarkers; Cross-Over Studies; Dabigatran; Drug Interactions; Humans; Metformin; Neoplasm Proteins; Organic Cation Transport Proteins; Pharmaceutical Preparations; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2022

Other Studies

2 other study(ies) available for metformin and dabigatran

Article	Year
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3 Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs	2013
Endothelial Dysfunction, Fibrinolytic Activity, and Coagulation Activity in Patients With Atrial Fibrillation According to Type II Diabetes Mellitus Status. The American journal of cardiology, 2020, 03-01, Volume: 125, Issue:5 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Carboxypeptidase B2; Case-Control Studies; Comorbidity; Cross-Sectional Studies; Dabigatran; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Endothelium, Vascular; Factor Xa Inhibitors; Female; Humans; Hypoglycemic Agents; Insulin; Italy; Male; Metformin; Peptide Fragments; Prothrombin; Sulfonylurea Compounds; von Willebrand Factor	2020

Article

Year

Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.

Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3

Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs

2013

Endothelial Dysfunction, Fibrinolytic Activity, and Coagulation Activity in Patients With Atrial Fibrillation According to Type II Diabetes Mellitus Status.

The American journal of cardiology, 2020, 03-01, Volume: 125, Issue:5

Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Carboxypeptidase B2; Case-Control Studies; Comorbidity; Cross-Sectional Studies; Dabigatran; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Endothelium, Vascular; Factor Xa Inhibitors; Female; Humans; Hypoglycemic Agents; Insulin; Italy; Male; Metformin; Peptide Fragments; Prothrombin; Sulfonylurea Compounds; von Willebrand Factor

2020